Sentinel Initiative Needs Better Defined Goals, Outside Review Concludes
This article was originally published in The Pink Sheet Daily
Executive Summary
The Pharmacovigilance Review Subcommittee of FDA's Science Board reports a lack of clarity within CDER over just what purpose the drug safety program is supposed to serve.